Acetazolamide to Prevent Impending Altitude-illness in Patients With COPD

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The purpose of this randomized, placebo-controlled double-blind trial is to evaluate efficacy of acetazolamide in preventing overt altitude-related adverse health effects (ARAHE) in lowlanders with chronic obstructive pulmonary disease (COPD) developing early signs of altitude-illness during altitude travel.
Epistemonikos ID: 0b2ef36520d5bbb9c60d7852848bedfa188adfa7
First added on: May 08, 2024